Patents by Inventor Thomas K. Tcheng
Thomas K. Tcheng has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20140046399Abstract: An implantable neurostimulator system for treating movement disorders includes a sensor, a detection subsystem capable of identifying episodes of a movement disorder by analyzing a signal received from the sensor, and a therapy subsystem capable of supplying therapeutic electrical stimulation to treat the movement disorder. The system treats movement disorders by detecting physiological conditions characteristic of an episode of symptoms of the movement disorder and selectively initiating therapy when such conditions are detected.Type: ApplicationFiled: October 21, 2013Publication date: February 13, 2014Applicant: NeuroPace, Inc.Inventors: Thomas K. TCHENG, Robert E. FISCHELL, Benjamin D. PLESS
-
Patent number: 8594795Abstract: An implantable neurostimulator system for treating movement disorders includes a sensor, a detection subsystem capable of identifying episodes of a movement disorder by analyzing a signal received from the sensor, and a therapy subsystem capable of supplying therapeutic electrical stimulation to treat the movement disorder. The system treats movement disorders by detecting physiological conditions characteristic of an episode of symptoms of the movement disorder and selectively initiating therapy when such conditions are detected.Type: GrantFiled: September 13, 2010Date of Patent: November 26, 2013Assignee: NeuroPace, Inc.Inventors: Thomas K. Tcheng, Robert E. Fischell, Benjamin D. Pless
-
Patent number: 8423145Abstract: An implantable neurostimulator system adapted to provide therapy for various neurological disorders is capable of varying therapy delivery strategies based on the context, physiological or otherwise, into which the therapy is to be delivered. Responsive and scheduled therapies can be varied depending on various sensor measurements, calculations, inferences, and device states (including elapsed times and times of day) to deliver an appropriate course of therapy under the circumstances.Type: GrantFiled: June 14, 2012Date of Patent: April 16, 2013Assignee: NeuroPace, Inc.Inventors: Benjamin D. Pless, Thomas K. Tcheng
-
Patent number: 8423156Abstract: Medical electrical lead systems and related methods are described. The lead systems may be configured to be at least partially implanted in neural tissue of a subject, such as a brain of a subject. Some variations of the lead systems may comprise a lead body, an electrode connected to the lead body, and a bioactive agent. The electrode and/or lead body may comprise a substrate, and the bioactive agent may be supported by the substrate (e.g., by a substantial portion of the area of the substrate). Methods described herein may comprise contacting the substrate of a lead body and/or an electrode of a medical electrical lead system with at least one bioactive agent, where the lead body and the electrode are connected to each other.Type: GrantFiled: February 9, 2012Date of Patent: April 16, 2013Assignee: NeuroPace, Inc.Inventors: C. Lance Boling, Daniel Chao, Martha J. Morrell, Benjamin D. Pless, Thomas K. Tcheng, Brett M. Wingeier
-
Publication number: 20120253417Abstract: An implantable neurostimulator system adapted to provide therapy for various neurological disorders is capable of varying therapy delivery strategies based on the context, physiological or otherwise, into which the therapy is to be delivered. Responsive and scheduled therapies can be varied depending on various sensor measurements, calculations, inferences, and device states (including elapsed times and times of day) to deliver an appropriate course of therapy under the circumstances.Type: ApplicationFiled: June 14, 2012Publication date: October 4, 2012Applicant: NeuroPace Inc.Inventors: Benjamin D. Pless, Thomas K. Tcheng
-
Publication number: 20120232628Abstract: Medical electrical lead systems and related methods are described. The lead systems may be configured to be at least partially implanted in neural tissue of a subject, such as a brain of a subject. Some variations of the lead systems may comprise a lead body, an electrode connected to the lead body, and a bioactive agent. The electrode and/or lead body may comprise a substrate, and the bioactive agent may be supported by the substrate (e.g., by a substantial portion of the area of the substrate). Methods described herein may comprise contacting the substrate of a lead body and/or an electrode of a medical electrical lead system with at least one bioactive agent, where the lead body and the electrode are connected to each other.Type: ApplicationFiled: February 9, 2012Publication date: September 13, 2012Applicant: NeuroPace, Inc.Inventors: C. Lance Boling, Daniel Chao, Martha J. Morrell, Benjamin D. Pless, Thomas K. Tcheng, Brett M. Wingeier
-
Patent number: 8224452Abstract: An implantable neurostimulator system adapted to provide therapy for various neurological disorders is capable of varying therapy delivery strategies based on the context, physiological or otherwise, into which the therapy is to be delivered. Responsive and scheduled therapies can be varied depending on various sensor measurements, calculations, inferences, and device states (including elapsed times and times of day) to deliver an appropriate course of therapy under the circumstances.Type: GrantFiled: May 17, 2011Date of Patent: July 17, 2012Assignee: NeuroPace Inc.Inventors: Benjamin D Pless, Thomas K Tcheng
-
Patent number: 8140152Abstract: Described here are intracranial ferrules, systems, and methods for sensing and stimulating neural tissues. The ferrules are generally designed to include a holding area for retaining an implantable device. In some variations, the ferrule itself may perform the sensing and stimulating functions. In other variations, the ferrule may function to sense data from neural tissues and the implantable device may function to stimulate neural tissues. In yet other variations, the ferrule may function to stimulate, and the implantable device may function to sense data from, the neural tissues. The sensing and stimulating functions may be used to detect and/or treat various neurological conditions.Type: GrantFiled: May 5, 2010Date of Patent: March 20, 2012Assignee: NeuroPace, Inc.Inventors: Michael S. John, Brett Wingeier, Thomas K. Tcheng, Benjamin D. Pless
-
Publication number: 20110218591Abstract: An implantable neurostimulator system adapted to provide therapy for various neurological disorders is capable of varying therapy delivery strategies based on the context, physiological or otherwise, into which the therapy is to be delivered. Responsive and scheduled therapies can be varied depending on various sensor measurements, calculations, inferences, and device states (including elapsed times and times of day) to deliver an appropriate course of therapy under the circumstances.Type: ApplicationFiled: May 17, 2011Publication date: September 8, 2011Applicant: NEUROPACE, INC.Inventors: Benjamin D. Pless, Thomas K. Tcheng
-
Patent number: 7966073Abstract: An implantable neurostimulator system adapted to provide therapy for various neurological disorders is capable of varying therapy delivery strategies based on the context, physiological or otherwise, into which the therapy is to be delivered. Responsive and scheduled therapies can be varied depending on various sensor measurements, calculations, inferences, and device states (including elapsed times and times of day) to deliver an appropriate course of therapy under the circumstances.Type: GrantFiled: May 16, 2006Date of Patent: June 21, 2011Assignee: NeuroPace, Inc.Inventors: Benjamin D. Pless, Thomas K. Tcheng
-
Publication number: 20110004282Abstract: Medical electrical lead systems and related methods are described. The lead systems may be configured to be at least partially implanted in neural tissue of a subject, such as a brain of a subject. Some variations of the lead systems may comprise a lead body, an electrode connected to the lead body, and a bioactive agent. The electrode and/or lead body may comprise a substrate, and the bioactive agent may be supported by the substrate (e.g., by a substantial portion of the area of the substrate). Examples of bioactive agents that may be used in the lead system include bioactive agents that promote neural adhesion and living cells that have been biologically manipulated, engineered cells, and cells of a particular phenotype and/or adapted to induce a desired neural or glial response.Type: ApplicationFiled: August 30, 2010Publication date: January 6, 2011Applicant: NEUROPACE, INC.Inventors: C. Lance Boling, Daniel Chao, Martha J. Morrell, Benjamin D. Pless, Thomas K. Tcheng, Brett M. Wingeier
-
Publication number: 20110004268Abstract: An implantable neurostimulator system for treating movement disorders includes a sensor, a detection subsystem capable of identifying episodes of a movement disorder by analyzing a signal received from the sensor, and a therapy subsystem capable of supplying therapeutic electrical stimulation to treat the movement disorder. The system treats movement disorders by detecting physiological conditions characteristic of an episode of symptoms of the movement disorder and selectively initiating therapy when such conditions are detected.Type: ApplicationFiled: September 13, 2010Publication date: January 6, 2011Applicant: NeuroPace, Inc.Inventors: Thomas K. Tcheng, Robert E. Fischell, Benjamin D. Pless
-
Publication number: 20100331717Abstract: A system and method for detecting and predicting neurological events with an implantable device uses a relatively low-power central processing unit in connection with signal processing circuitry to identify features (including half waves) and calculate window-based characteristics (including line lengths and areas under the curve of the waveform) in an electrographic signal received from a patient's brain. The features and window-based characteristics are combinable in various ways according to the invention to detect and predict neurological events in real time, enabling responsive action by the implantable device.Type: ApplicationFiled: September 12, 2010Publication date: December 30, 2010Applicant: NEUROPACE, INC.Inventors: Benjamin D. Pless, Stephen T. Archer, Craig M. Baysinger, Barbara Gibb, Suresh Gurunathan, Bruce Kirkpatrick, Thomas K. Tcheng
-
Patent number: 7844345Abstract: Medical electrical lead systems and related methods are described. The lead systems may be configured to be at least partially implanted in neural tissue of a subject, such as a brain of a subject. Some variations of the lead systems may comprise a lead body, an electrode connected to the lead body, and a bioactive agent. The electrode and/or lead body may comprise a substrate, and the bioactive agent may be supported by the substrate (e.g., by a substantial portion of the area of the substrate). Examples of bioactive agents that may be used in the lead system include antiproliferative agents, bactericidal agents, bacteriostatic agents, antiepileptic agents, and/or antifungal agents. Methods described herein may comprise coating a lead body and/or an electrode of a medical electrical lead system with at least one bioactive agent, where the lead body and the electrode are connected to each other.Type: GrantFiled: February 8, 2007Date of Patent: November 30, 2010Assignee: NeuroPace, Inc.Inventors: C. Lance Boling, Daniel Chao, Martha J. Morrell, Benjamin D. Pless, Thomas K. Tcheng, Brett M. Wingeier
-
Patent number: 7813793Abstract: A system and method for detecting and predicting neurological events with an implantable device uses a relatively low-power central processing unit in connection with signal processing circuitry to identify features (including half waves) and calculate window-based characteristics (including line lengths and areas under the curve of the waveform) in an electrographic signal received from a patient's brain. The features and window-based characteristics are combinable in various ways according to the invention to detect and predict neurological events in real time, enabling responsive action by the implantable device.Type: GrantFiled: October 25, 2004Date of Patent: October 12, 2010Assignee: NeuroPace, Inc.Inventors: Benjamin D. Pless, Stephen T. Archer, Craig M. Baysinger, Barbara Gibb, Suresh Gurunathan, Bruce Kirkpatrick, Thomas K. Tcheng
-
Patent number: 7813802Abstract: An implantable neurostimulator system for treating movement disorders includes a sensor, a detection subsystem capable of identifying episodes of a movement disorder by analyzing a signal received from the sensor, and a therapy subsystem capable of applying therapeutic electrical stimulation to treat the movement disorder. The system treats movement disorders by detecting physiological conditions characteristic of an episode of symptoms of the movement disorder and selectively initiating therapy when such conditions are detected.Type: GrantFiled: September 8, 2006Date of Patent: October 12, 2010Assignee: NeuroPace, Inc.Inventors: Thomas K. Tcheng, Robert E. Fischell, Benjamin D. Pless
-
Publication number: 20100217341Abstract: Described here are intracranial ferrules, systems, and methods for sensing and stimulating neural tissues. The ferrules are generally designed to include a holding area for retaining an implantable device. In some variations, the ferrule itself may perform the sensing and stimulating functions. In other variations, the ferrule may function to sense data from neural tissues and the implantable device may function to stimulate neural tissues. In yet other variations, the ferrule may function to stimulate, and the implantable device may function to sense data from, the neural tissues. The sensing and stimulating functions may be used to detect and/or treat various neurological conditions.Type: ApplicationFiled: May 5, 2010Publication date: August 26, 2010Applicant: NEUROPACE, INC.Inventors: Michael S. John, Brett Wingeier, Thomas K. Tcheng, Benjamin D. Pless
-
Patent number: 7747318Abstract: Described here are intracranial ferrules, systems, and methods for sensing and stimulating neural tissues. The ferrules are generally designed to include a holding area for retaining an implantable device. In some variations, the ferrule itself may perform the sensing and stimulating functions. In other variations, the ferrule may function to sense data from neural tissues and the implantable device may function to stimulate neural tissues. In yet other variations, the ferrule may function to stimulate, and the implantable device may function to sense data from, the neural tissues. The sensing and stimulating functions may be used to detect and/or treat various neurological conditions.Type: GrantFiled: December 7, 2006Date of Patent: June 29, 2010Assignee: NeuroPace, Inc.Inventors: Michael S. John, Brett Wingeier, Thomas K. Tcheng, Benjamin D. Pless
-
Publication number: 20080195227Abstract: Medical electrical lead systems and related methods are described. The lead systems may be configured to be at least partially implanted in neural tissue of a subject, such as a brain of a subject. Some variations of the lead systems may comprise a lead body, an electrode connected to the lead body, and a bioactive agent. The electrode and/or lead body may comprise a substrate, and the bioactive agent may be supported by the substrate (e.g., by a substantial portion of the area of the substrate). Examples of bioactive agents that may be used in the lead system include antiproliferative agents, bactericidal agents, bacteriostatic agents, antiepileptic agents, and/or antifungal agents. Methods described herein may comprise coating a lead body and/or an electrode of a medical electrical lead system with at least one bioactive agent, where the lead body and the electrode are connected to each other.Type: ApplicationFiled: February 8, 2007Publication date: August 14, 2008Inventors: C. Lance Boling, Daniel Chao, Martha J. Morrell, Benjamin D. Pless, Thomas K. Tcheng, Brett M. Wingeier
-
Publication number: 20080140149Abstract: Described here are intracranial ferrules, systems, and methods for sensing and stimulating neural tissues. The ferrules are generally designed to include a holding area for retaining an implantable device. In some variations, the ferrule itself may perform the sensing and stimulating functions. In other variations, the ferrule may function to sense data from neural tissues and the implantable device may function to stimulate neural tissues. In yet other variations, the ferrule may function to stimulate, and the implantable device may function to sense data from, the neural tissues. The sensing and stimulating functions may be used to detect and/or treat various neurological conditions.Type: ApplicationFiled: December 7, 2006Publication date: June 12, 2008Inventors: Michael S. John, Brett Wingeier, Thomas K. Tcheng, Benjamin D. Pless